Moreover, an association between high levels of TNF-α and the activation of NF-κB has been found in the skin of patients with psoriasis; and therefore, a possible mechanism of action of anti-TNFα drugs would be, at least in part, the inhibition of the transcriptional activity of NF-κB [13], as we will see later. Here, NFKB1 is linked to psoriasis.